PropertyValue
?:abstract
  • Biased seroprevalence estimates can occur using serological assays optimized with validation sets unrepresentative of disease spectrum in the general population. Correct interpretation of serosurveys for severe acute respiratory syndrome coronavirus 2 requires quantifying variations in sensitivity with disease severity and over time.
is ?:annotates of
?:creator
?:journal
  • J_Infect_Dis
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
?:type
?:who_covidence_id
  • #919300
?:year
  • 2020

Metadata

Anon_0  
expand all